Skip to content

Cardiology Biobank Registry

Cardiology Biobank Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00378924
Enrollment
12000
Registered
2006-09-21
Start date
2003-12-01
Completion date
2030-04-01
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Brief summary

In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers. Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively. By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.

Detailed description

Over the last several decades, scientists have made great progress in their understanding of cardiovascular disease. Nevertheless, much remains to be learned about the causes, course, and treatment of cardiovascular disease. In order to learn more about this topic, it is important to establish large databases of cardiovascular patients. These databases allows scientists to investigate, in a rigorous and precise manner, those factors that influence cardiovascular disease. In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers. Investigators will collect a large amount of data on these patients. Data to be collected will include information on: Medical record data, including imaging Patient questionnaire data DNA and other biochemical data obtained and/or generated from patient blood samples or cheek (buccal) swabs Non-invasive measurements of blood pressure, heart rate and studies relating to assessment of the health of arteries The data noted above will be collected by: administering questionnaires/interviews to the patients accessing the medical records of the patients collecting blood samples from patients which will be analyzed by laboratories for their biochemical content. Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help investigators to understand how these diseases can be treated more effectively. How the Research Will Advance Scientific Knowledge/Human Health: By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.

Interventions

None listed

Sponsors

Emory University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. All hospital and clinic participants aged 18 years and older 2. Participants with and without active or presumed cardiovascular disease including but not limited to: 1. Coronary Artery Disease 2. Heart Failure and Cardiomyopathies 3. Peripheral Vascular Disease 4. Valve disease 5. Adult Congenital Heart disease 6. Electrophysiological Disorders 3. Any individual aged 18 and above in satisfactory physical health and able to tolerate a blood draw or buccal swab.

Exclusion criteria

1. Significant Documented Anemia (Hemoglobin \<8 g/dL) 2. Blood transfusions within past 3 weeks 3. Enrollment against doctor recommendation 4. Participant not able to provide consent including but not limited to: 1. Intubated and critically unwell participants 2. Dementia 3. Alzheimer's disease 4. Moderate to severe alcohol or drug abuse 5. Against religious beliefs (e.g. Jehovah's witness)

Design outcomes

Primary

MeasureTime frame
All cause deathContinuous

Secondary

MeasureTime frame
Cardiovascular deathContinuous
Re-hospitalization for heart failureContinuous

Countries

United States

Contacts

CONTACTAyman J Tahhan, MD
ayman.tahhan@emory.edu404 712 0168
CONTACTSalman Sher, MD
ssher2@emory.edu404 412 0170
PRINCIPAL_INVESTIGATORArshed A Quyyumi, MD

Emory School Of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026